The antitumor activity of bismuth lipophilic nanoparticles (BisBAL NPs) on human glioblastoma is higher than temozolomide
Bio-Medical Materials and Engineering · 2026
DOI: 10.1177/09592989251414231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bio-Medical Materials and Engineering, 2026. Verfasst von Gustavo Israel Martinez-Gonzalez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biología Molecular, Facultad de Odontología, Universidad Autónoma de Nuevo León (UANL), Monterrey, Nuevo León, México. Hauptthemen laut MEDLINE: Glioblastoma, Dacarbazine, Bismuth, Nanoparticles. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Facultad de Ciencias Naturales y Museo, Universidad Nacional de La Plata.
Abstract (Originalsprache)
Background
Glioblastoma multiforme (GBM) is the most common type of brain tumor and it is considered as one of the most aggressive malignancies (1.5 years of survival rate).
Objective
Determine the antitumor potential of bismuth lipophilic nanoparticles (BisBAL NP) on a human glioblastoma cell-line.
Methods
BisBAL NP were characterized by scanning electron microscopy (SEM). BisBAL NP entry and intracellular distribution on U-87 MG cells were observed by transmission electron microscopy (TEM). The effect of BisBAL NP on tumor cells was evaluated by MTT assay (IC 50 value), Calcein AM staining, Live/dead assay, apoptosis quantification, and comet assay.
Results
BisBAL NP-induced cytotoxicity more efficient than temozolomide (TMZ). The IC 50 value of BisBAL NP was 12.7 µM. For the first time, direct interaction between BisBAL NP and plasmatic U-87 MG cell membrane was obtained by TEM. Calcein AM assay revealed loss of permeability of tumor cells after 24 h-exposure to 25 µM of BisBAL NP. 25 µM of BisBAL induced 48.5% of apoptosis, while 50 µM of BisBAL induced a higher rate of apoptosis 77.2%.
Conclusion
BisBAL NP inhibited U-87 MG cell growth through membrane attack and loss membrane permeability, apoptosis induction and later promoting genotoxicity among tumor cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Biología Molecular, Facultad de Odontología, Universidad Autónoma de Nuevo León (UANL), Monterrey, Nuevo León, México.
- Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Ciudad de México, México.
- Departamento de Ciencias Básicas, Universidad de Monterrey, San Pedro Garza García, México.
ORCID-Profile: Gustavo Israel Martinez-Gonzalez, Rene Hernández-Delgadillo, Yesennia Sánchez-Pérez, Claudia María García-Cuellar, Irene Meester, Claudio Cabral-Romero
Förderung
- Facultad de Ciencias Naturales y Museo, Universidad Nacional de La Plata
Zitieren
APA
Martinez-Gonzalez, G. I., Hernández-Delgadillo, R., Ramos-Godinez, M. D. P., Oliva-Rico, D. A., López-Saavedra, A., Quezada-Maldonado, M., Sánchez-Pérez, Y., García-Cuellar, C. M., Meester, I., & Cabral-Romero, C. (2026). The antitumor activity of bismuth lipophilic nanoparticles (BisBAL NPs) on human glioblastoma is higher than temozolomide. Bio-Medical Materials and Engineering. https://doi.org/10.1177/09592989251414231
Vancouver
Martinez-Gonzalez GI, Hernández-Delgadillo R, Ramos-Godinez MDP, Oliva-Rico DA, López-Saavedra A, Quezada-Maldonado M, et al. The antitumor activity of bismuth lipophilic nanoparticles (BisBAL NPs) on human glioblastoma is higher than temozolomide. Bio-Medical Materials and Engineering. 2026. doi:10.1177/09592989251414231
BibTeX
@article{MartinezGonzalez2026,
author = {Martinez-Gonzalez, Gustavo Israel and Hernández-Delgadillo, Rene and Ramos-Godinez, María Del Pilar and Oliva-Rico, Diego Adrian and López-Saavedra, Alejandro and Quezada-Maldonado, Marel and Sánchez-Pérez, Yesennia and García-Cuellar, Claudia María and Meester, Irene and Cabral-Romero, Claudio},
title = {The antitumor activity of bismuth lipophilic nanoparticles (BisBAL NPs) on human glioblastoma is higher than temozolomide},
journal = {Bio-Medical Materials and Engineering},
year = {2026},
doi = {10.1177/09592989251414231}
}
EUVIMED